Targeted Polyethylene Glycol Gold Nanoparticles for the Treatment of Pancreatic Cancer: From Synthesis to Proof-of-Concept in vitro Studies [Corrigendum]

Abstract

Spadavecchia J, Movia D, Moore C, et al. Int J Nanomedicine. 2016;11:791–822. Page 815, Figure S6, the following copyright notice should have been included in the figure caption. Copyright ©2016. Elsevier. Reproduced from Spadavecchia J, Perumal R, Casale S, Krafft JM, Methivier C, Pradier CM. Polyethylene glycol gold-nanoparticles: Facile nanostructuration of doxorubicin and its complex with DNA molecules for SERS detection. Chem Phys Lett. 2016;648:182–188.1 Page 822, the following reference should have been included in a new reference list for the supplementary materials. 1. Spadavecchia J, Perumal R, Casale S, Krafft JM, Methivier C, Pradier CM. Polyethylene glycol gold-nanoparticles: Facile nanostructuration of doxorubicin and its complex with DNA molecules for SERS detection. Chem Phys Lett. 2016;648:182–188. doi 10.2147/IJN.S97476 The authors apologize for this error.

Keywords

• pegylated gold nanoparticles
• doxorubicin
• potassium channel targeting
• herg1
• pancreatic cancer
• antibody-drug conjugate.